![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Delcuve Geneviève P Khan Dilshad H Davie James R
Publisher: Informa Healthcare
ISSN: 1472-8222
Source: Expert Opinion on Therapeutic Targets, Vol.17, Iss.1, 2013-01, pp. : 29-41
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting Histone Deacetylases in Neuroblastoma
Current Pharmaceutical Design, Vol. 15, Iss. 4, 2009-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting histone deacetylases for heart failure
By Bush Erik W McKinsey Timothy A
Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. :